Related references
Note: Only part of the references are listed.Temporal trends in treatment and survival of older adult diffuse large B-Cell lymphoma patients in the SEER-Medicare linked database
Jaime Shaw et al.
LEUKEMIA & LYMPHOMA (2019)
Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment
Yang Liu et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience
Gilles Salles et al.
ADVANCES IN THERAPY (2017)
Cardiac Lymphoma
Jean Jeudy et al.
RADIOLOGIC CLINICS OF NORTH AMERICA (2016)
Primary cardiac lymphoma: two cases and a review of literature
Karolis Jonavicius et al.
JOURNAL OF CARDIOTHORACIC SURGERY (2015)
Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
Matthew J. Maurer et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Diffuse large B-cell lymphoma
Maurizio Martelli et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Primary Cardiac Lymphoma An Analysis of Presentation, Treatment, and Outcome Patterns
Adam Petrich et al.
CANCER (2011)
Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
Bertrand Coiffier et al.
BLOOD (2010)
Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation - a population-based study of 1575 cases
MB Moller et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Clinical perspectives of primary cardiac lymphoma
RM Gowda et al.
ANGIOLOGY (2003)
Share Paper
